Marksans Pharma Ltd

MARKSANS

Company Profile

  • Business description

    Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal, and oncologic drugs as well as antibiotics and antiallergic medications. Geographically, the majority of its revenue is generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, and the Rest of the World.

  • Contact

    Veera Desai Extension Road
    11th Floor, Grandeur
    Opposite Gundecha Symphony
    Oshiwara, Andheri (West)
    MumbaiMH400053
    IND

    T: +91 2240012000

    https://www.marksanspharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 March 2027

    Employees

    2,657

Stocks News & Analysis

stocks

Corning’s AI fiber boom is real, but its stock price may be getting out of hand

Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
stocks

Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?

From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks

ASX energy share remains cheap despite strong outlook

Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,933.2016.20-0.18%
CAC 408,141.9215.90-0.19%
DAX 4024,083.5345.45-0.19%
Dow JONES (US)49,167.7962.92-0.13%
FTSE 10010,321.0957.99-0.56%
HKSE25,663.95261.70-1.01%
NASDAQ24,887.1050.500.20%
Nikkei 22559,850.50686.86-1.13%
NZX 50 Index12,764.40110.54-0.86%
S&P 5007,173.918.830.12%
S&P/ASX 2008,709.7011.50-0.13%
SSE Composite Index4,077.049.30-0.23%

Market Movers